NEUBERGER BERMAN GROUP LLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1465109 NEW YORK, NY

Position in PTCT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$8,281,132

-$195,243 QoQ

Shares Held

121,549

+8.9% QoQ

Ownership

0.147%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 99.95310533200602.ToString("F0")% Shared 0.ToString("F0")% None 0.046894667993977734.ToString("F0")%

Healthcare · as of Mar 31, 2026

NEUBERGER BERMAN GROUP LLC holds $1,136,881,142 across 81 Biotechnology names. PTCT ranks #15 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,129	$330,016,949
2	VRTX	Vertex Pharmaceuticals Inc / Ma	551,522	$246,276,633
3	TECH	BIO-TECHNE Corp	3,340,837	$174,592,141
4	CAI	Caris Life Sciences, Inc.	3,590,586	$64,199,677
5	INSM	INSMED Inc	270,700	$44,264,863
6	IONS	Ionis Pharmaceuticals Inc	443,272	$33,285,294
7	ALNY	Alnylam Pharmaceuticals, Inc.	93,496	$30,935,021
8	TERN	Terns Pharmaceuticals, Inc.	480,740	$25,344,612

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,281,132	121,549	+8.9%	Shares	Defined	2026-05-14
2025-12-31	$8,476,375	111,590	+2993.7%	Shares	Defined	2026-02-13
2025-09-30	$221,360	3,607	-78.0%	Shares	Defined	2025-11-12
2022-09-30	$821,472	16,364	-32.2%	Shares	Defined	2022-11-15
2021-03-31	$1,143,076	24,141	-62.0%	Shares	Defined	2021-05-13
2020-12-31	$3,875,405	63,500	0.0%	Shares	Defined	2021-02-10
2020-09-30	$2,968,625	63,500	+15.5%	Shares	Defined	2020-11-12
2020-03-31	$2,453,550	55,000	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.